NASDAQ:PRXL PAREXEL International (PRXL) Stock Price, News & Analysis → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free PRXL Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$88.08▼$88.0850-Day Range$88.08▼$88.0852-Week Range$51.16▼$88.10VolumeN/AAverage Volume1.04 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get PAREXEL International alerts: Email Address Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About PAREXEL International Stock (NASDAQ:PRXL)PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries. Its segments include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI). The CRS segment includes various phases of clinical research from first-in-man trials, where a medicinal entity is tested on human subjects for the first time, through post-marketing studies, following approval by the presiding regulatory body. The PC segment provides technical expertise and advice in areas, such as strategy, drug development, regulatory affairs, strategic compliance and targeted communications services in support of product launch. The Company's PI segment provides information technology solutions.Read More Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… PRXL Stock News HeadlinesAugust 29, 2023 | finance.yahoo.comParexel and Partex Announce Innovative Alliance Leveraging Artificial Intelligence and Big Data to Accelerate Drug Discovery and DevelopmentJune 23, 2023 | technews.tmcnet.comParexel Announces Updates to Board of DirectorsMarch 28, 2024 | MarketBeat (Ad)Your $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionMay 17, 2023 | thestreet.comParexel to Be Taken Off Market by Private EquityMay 17, 2023 | finance.yahoo.comParexel Appoints Scott Smith, M.D., Ph.D. as New Head of HematologyApril 2, 2023 | thestreet.comParexel International Stock Hits New 52-Week High (PRXL)November 2, 2022 | seekingalpha.comIQVIA Holdings Sees Digital Opportunities, But Debt Drags GrowthOctober 16, 2022 | ca.finance.yahoo.comParexel Recognized by Frost & Sullivan with 2022 Global Customer Value Leadership AwardMarch 28, 2024 | MarketBeat (Ad)Your $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionSeptember 21, 2022 | finance.yahoo.comParexel’s Peyton Howell Awarded Prestigious PharmaVoice Red JacketSeptember 17, 2022 | technews.tmcnet.comParexel's Peyton Howell Awarded Prestigious PharmaVoice Red JacketSeptember 8, 2022 | finance.yahoo.comParexel’s Jim Anthony Named to 2022 PharmaVOICE 100September 7, 2022 | thestreet.comStarboard's Smith Launches Campaign To Ensure Parexel Finds a BuyerJune 16, 2022 | finance.yahoo.comParexel Expands Patient Access to Clinical Trials Through New Community Alliance NetworkSee More Headlines Receive PRXL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PAREXEL International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:PRXL CUSIP69946210 CIK799729 Webwww.parexel.com Phone+1-781-4879900FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesJosef H. von RickenbachChairman of the Board, Chief Executive OfficerMark A. Goldberg M.D.President, Chief Operating OfficerSimon HarfordChief Financial Officer, Senior Vice PresidentBio & Compensation - Xavier AB FlinoisPresident - PAREXEL InformaticsMichelle GrahamChief Human Resource Officer, Senior Vice PresidentSybrand Pretorius M.D.Senior Vice President, Chief Scientific OfficerDouglas Alexander BattSenior Vice President, General Counsel, SecretaryRoland Andersson Ph.d.Senior Vice President - Clinical Research ServicesChristian Dreger Ph.D.Senior Vice President - Parexel Access and Parexel ConsultingBio & Compensation - David J. GodwinSenior Vice President-Global BusinessMore Executives PRXL Stock Analysis - Frequently Asked Questions What other stocks do shareholders of PAREXEL International own? Based on aggregate information from My MarketBeat watchlists, some companies that other PAREXEL International investors own include Universal Display (OLED), Allergan (AGN), Baidu (BIDU), Gilead Sciences (GILD), ICON Public (ICLR), Intel (INTC), Netflix (NFLX), Royal Bank of Canada (RY) and Skyworks Solutions (SWKS). This page (NASDAQ:PRXL) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAREXEL International Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.